Onderneming SMS Pharmaceuticals Limited Bombay S.E.
Aandelen
SMSPHARMA
INE812G01025
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
198 INR | -0,40% | -3,27% | +66,84% |
Vakgebied
Aantal werknemers: 1 095
Verkoop per activiteit
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
95,9
%
| 5 072 | 97,6 % | 5 008 | 95,9 % | -1,27% |
Services
2,0
%
| - | - | 104 | 2,0 % | - |
Conversion Charges
1,7
%
| 78 | 1,5 % | 86 | 1,7 % | +10,18% |
Export Incentives
0,4
%
| 49 | 0,9 % | 23 | 0,4 % | -52,57% |
Verkoop per regio
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
India
100,0
%
| 5 199 | 100,0 % | 5 221 | 100,0 % | +0,42% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 64 | 30-08-90 | |
Director of Finance/CFO | - | 13-09-17 | |
Tirumalesh Tumma
CMP | Compliance Officer | - | 16-02-22 |
Director/Board Member | 35 | 09-08-13 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 64 | 30-08-90 | |
Director/Board Member | 60 | 12-08-19 | |
Director/Board Member | 67 | 12-08-14 | |
Director/Board Member | 35 | 09-08-13 | |
Director/Board Member | - | 12-08-14 | |
Director/Board Member | 46 | 29-05-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 84 652 000 | 23 380 661 ( 27,62 %) | 0 | 27,62 % |
Bedrijfsgegevens
SMS Pharmaceuticals Ltd.
Plot No. 72, H.No. 8-2-334/3 & 4 Road No.5, Opp.SBI Executive Enclave
500034, Hyderabad
+91 40 2525 9999
http://www.smspharma.comSector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
+15,91% | 41,97 mld. | |
+22,40% | 22,34 mld. | |
+18,48% | 15,25 mld. | |
+16,12% | 14 mld. | |
+45,12% | 12,06 mld. | |
-9,58% | 6,8 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+14,18% | 5,49 mld. |
- Beurs
- Aandelen
- Koers SMSPHARMA
- Koers SMSPHARMA
- Onderneming SMS Pharmaceuticals Limited